Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.64 |
| ▸ | CA12 | O43570 | 2/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.61 |
| ▸ | CA9 | Q16790 | 2/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | CES2 | O00748 | 3/20 | 0.50 |
| ▸ | CES1 | P23141 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | DAO | P14920 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11498687 | 1.00 | NFE2L2 (0.64) | NFE2L2CA12CA1CA2CA9 | |
| SCHEMBL10304521 | 1.00 | NFE2L2 (0.64) | NFE2L2CA12CA1CA2CA9 | |
| SCHEMBL15454973 | 0.98 | NFE2L2 (0.61) | NFE2L2CA12CA1CA2CA9 | |
| SCHEMBL15454975 | 0.98 | NFE2L2 (0.61) | NFE2L2CA12CA1CA2CA9 | |
| SCHEMBL4449994 | 0.84 | NFE2L2 (0.50) | NFE2L2CA12CA1CA2CA9 | |
| SCHEMBL26147588 | 0.82 | ALDH1A1 (0.59) | NFE2L2MAPTKDM4EHPGDSMN1; SMN2 | |
| SCHEMBL26163201 | 0.82 | CA12 (0.50) | NFE2L2CA12CA1CA2CA9 | |
| SCHEMBL566351 | 0.81 | DEGS1 (0.53) | NFE2L2CA12CA1CA2CA9 | |
| SCHEMBL566350 | 0.81 | DEGS1 (0.53) | NFE2L2CA12CA1CA2CA9 | |
| SCHEMBL4863098 | 0.81 | CES2 (0.50) | NFE2L2CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250033082-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2025-01-30 | — | — | US | claimed |
| EP-4423178-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2024-09-04 | — | — | EP | claimed |
| CN-118201991-A | Methods and compositions for reducing solvent release from agrochemical formulations and reducing agrochemical formulation odor | 安道麦马克西姆有限公司 | 2024-06-14 | — | — | CN | claimed |
| EP-4259812-A1 | METHOD FOR THE PREPARATION OF FRAMBINONE | SPECIALTY OPERATIONS FRANCE (FR) | 2023-10-18 | — | — | EP | claimed |
| WO-2023073536-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2023-05-04 | — | — | WO | claimed |
| WO-2022129012-A1 | METHOD FOR THE PREPARATION OF FRAMBINONE | RHODIA OPERATIONS (FR) | 2022-06-23 | — | — | WO | claimed |
| CN-103923061-A | Heterocyclic 1,4-pentadiene-3-ketoxime compound as well as preparation method and application thereof | UNIV GUIZHOU | 2014-07-16 | — | — | CN | claimed |
| CN-103896865-A | 1,4-pentadiene-3-ketone compounds containing triazole amide and preparation method and application thereof | XINGYI NORMAL UNIVERSITY FOR NATIONALITIES | 2014-07-02 | — | — | CN | claimed |
| US-20250327100-A1 | Strain of Pseudomonas Putida Genetically Modified to Express a Benzalacetone Reductase | BGENE GENETICS (FR) | 2025-10-23 | — | — | US | disclosed |
| US-20250171750-A1 | Modified Polyketide Synthase Enzymes and Uses Thereof | BGENE GENETICS (FR) | 2025-05-29 | — | — | US | disclosed |
| EP-4560015-A2 | MODIFIED POLYKETIDE SYNTHASE ENZYMES AND USES THEREOF | BGene Genetics (FR) | 2025-05-28 | — | — | EP | disclosed |
| EP-4370674-A1 | STRAIN OF PSEUDOMONAS PUTIDA GENETICALLY MODIFIED TO EXPRESS A BENZALACETONE REDUCTASE | BGene Genetics (FR) | 2024-05-22 | — | — | EP | disclosed |
| WO-2023230574-A1 | ENGINEERED PHENYLALANINE AMMONIA LYASE AND TYROSINE AMMONIA LYASE ENZYMES FOR PRODUCING AROMATIC COMPOUNDS | GINKGO BIOWORKS, INC. (US) | 2023-11-30 | — | — | WO | disclosed |
| EP-4259812-A1 | METHOD FOR THE PREPARATION OF FRAMBINONE | SPECIALTY OPERATIONS FRANCE (FR) | 2023-10-18 | — | — | EP | disclosed |
| EP-2689020-A1 | MICROBIAL PRODUCTION OF CHEMICAL PRODUCTS AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | OPX Biotechnologies Inc. (US) | 2014-01-29 | — | — | EP | disclosed |
| US-20130122541-A1 | MICROORGANISM PRODUCTION OF HIGH-VALUE CHEMICAL PRODUCTS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | THE REGENTS OF THE UNIVERSITY OF COLORADO | 2013-05-16 | — | — | US | disclosed |
| WO-2012129450-A1 | MICROBIAL PRODUCTION OF CHEMICAL PRODUCTS AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | OPX BIOTECHNOLOGIES, INC. (US) | 2012-09-27 | — | — | WO | disclosed |
| US-20120046247-A1 | 1,5-DIPHENYL-PENTA-1,4-DIEN-3-ONE COMPOUNDS | ALLIANZ PHARMASCIENCE LTD. (TW) | 2012-02-23 | — | — | US | disclosed |
| US-5951841-A | ACIDIC ELECTROPLATING BATHS COMPRISING BRIGHTENERS FOR THE ELECTROLYTIC DEPOSITION OF METALLIC INORGANIC LAYERS ONTO SHAPED ARTICLES | BASF AKTIENGESELLSCHAFT (DE) | 1999-09-14 | — | — | US | disclosed |
| US-4182861-A | OPTICAL BRIGHTENERS FOR POLYESTER, COTTON, POLYAMIDE AND POLYACRYLONITRILE FABRICS, POLYVINYL CHLORIDE FOILS | SANDOZ LTD. (CH) | 1980-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046247-A1 | 1,5-DIPHENYL-PENTA-1,4-DIEN-3-ONE COMPOUNDS | PDCD5, IL5, MALT1 | NFE2L2 957/4885CA12 2222/4885CA1 1589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.